Prime Minister Narendra Modi on 15 August 2025 set sweeping global ambitions for Indian industry, urging pharmaceutical companies to break into the ranks of the world's five largest pharma firms and calling for 50 Indian companies to feature on the Fortune 500 list. The targets, announced from the ramparts of the Red Fort during his 80th Independence Day address, signal a shift in the government's economic narrative — from domestic growth to global dominance.

The Pharma Ambition

Modi framed India's pharmaceutical sector as being at an inflection point, describing its trajectory as moving from being the pharmacy of the world to an emerging hub of innovation. He called on Indian pharma firms to ascend the global value chain through sustained investment in research and development, biologics, biosimilars, and next-generation therapies.

'From the pharmacy of the world to a hub of innovation, India's pharma sector is moving up the value chain,' Modi said in a post on X. 'Under the present government, the focus has been on extensive R&D, biologics, biosimilars and cutting-edge therapies,' he added.

Med-Tech Momentum

Beyond pharmaceuticals, Modi highlighted India's growing stature as a global med-tech partner. He pointed to reduced import dependence, domestic manufacturing expansion, and continued foreign investment as indicators of rising investor confidence. More than 50 high-end medical devices have begun domestic production under the Production-Linked Incentive (PLI) scheme, he noted.

India's med-tech market is currently valued at $15–16 billion and is expanding at nearly 12% annually, making it the fourth-largest medical technology market in Asia and among the top 20 globally. According to a recent industry report, the domestic medical device sector is projected to reach a market size of $250 billion by 2047.

Fortune 500 and the Broader Corporate Push

Modi's Independence Day address extended beyond pharma, setting a broader benchmark for Indian corporate ambition. He emphasised that India's economic growth must be accompanied by the emergence of globally competitive companies with an expanded international footprint. The call for 50 Indian companies on the Fortune 500 is a significant leap — currently, only a handful of Indian firms feature on the list.

This comes amid India's sustained positioning as one of the world's fastest-growing major economies, with the government increasingly pushing for Indian brands and businesses to match that scale on the global stage.

What Comes Next

The targets set from the Red Fort are aspirational benchmarks rather than policy mandates, but they are expected to shape the government's sectoral priorities in the months ahead. Industry bodies and pharma associations are likely to engage with the Centre on a roadmap that translates these ambitions into regulatory, funding, and trade-policy action. The PLI scheme's expansion into high-end medical devices is seen as an early structural step in that direction.